Altria Group (MO)
$44.49 0.16 (0.36%)
5:15 EDT MO Stock Quote Delayed 15 Minutes
Previous Close $44.33
Market Cap 84.20B
PE Ratio 7.96
Volume (Avg. Vol.) 801
Day's Range 44.33 - 44.33
52-Week Range 39.30 - 66.04
Dividend & Yield 2.86 (6.43%)
MO Stock Predictions, Articles, and Altria Group News
- From InvestorPlace
- From the Web
If Altria stock can thrive amid decades of anti-smoking crusades and costly lawsuits, it can also survive the controversy surrounding Juul.
Despite public opinion turning against tobacco, these three tobacco stocks have high dividends and potential to profit from marijuana.
The Altria stock price has plunged amid concerns about vaping and the company's debt load. But MO stock should come out just fine.
While I believe that regulators will ultimately get this entire health scare sorted and both Juul and Cronos will go back to running their businesses, I can’t help but think how relieved Altria’s management must be that they made the $1.8 billion investment in Cronos in exchange for 45% of its stock.
On it's surface, Altria stock looks cheap. But less demand for tobacco products and vaping crisis headlines mean its fairly valued for now.
Like 2018, the market looks like it may be setting up for another rocky Q4. Here's your guide on which defensive high-yield stocks to buy, and which to avoid.
Cronos Group was already struggling to turn a profit and gain market share. Now the deterioration of a growth prospect could completely up-end CRON stock.
Turning Point Brands, Cronos Group and Altria are just some of the stocks to buy or sell here at a pivotal time for vaporizers.
Altria and Philip Morris calling off their merger made waves on Wednesday. Here's what else happened in the stock market today.
PM stock is on the rise Wednesday after Philip Morris (PM) and Altria (MO) announced an end to merger discussions and plans for the future.
With the vaping crisis turning Altria stock into a whipping boy, shares have understandably gone volatile. Yet the finer details of this matter suggest that Altria could still be a winner over the long haul.
CRON stock has suffered in recent days due to growing concern about vaping. But Altria should help CRON weather the storm.
By Theodore Kim
CRON stock could continue to show strong revenue growth, making this dip a great buying opportunity in Cronos.
Cronos Group stock may not be attractive to institutions with ESG concerns. That is because its deal with Altria makes it a sin stock.
Apple's iPhone unveil date is out, and Microsoft is reportedly taking market share from Amazon. Here's what happened in the stock market today.
International tobacco sales are finally rolling over, so merging Altria's pot and vaping investments into Philip Morris makes sense.
Like other cannabis investments, Aurora Cannabis stock has suffered incredible volatility recently. In order to generate some confidence, ACB stock must start justifying its rich premium.
From The Motley Fool
From The Street
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!